Key facts
- This page summarizes William Geist Power's Form 4 filing for BIO-TECHNE Corp (TECH).
- 3 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2022, 18:15.
William Geist Power - 15 Aug 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)
- Reporting relationship
- PRESIDENT, PROTEIN SCIENCES
- Issuer ticker
- TECH
- Reported as of
- 15 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Aug 2022, 18:15:43 UTC
- Prior SEC filing
- 29 Sep 2022
- Next SEC filing
- 14 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brenda S. Furlow as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William Geist Power filed Form 4 for BIO-TECHNE Corp (TECH) on 17 Aug 2022.
Change
- Previous filing in this sequence was filed on 29 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TECH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,490
- Date
- 15 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TECH
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +1,785
- Change %
- Price
- $0.000000
- Shares after
- 1,785
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,785
- Exercise price
- Footnotes
- F2, F3
TECH
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +5,550
- Change %
- Price
- $0.000000
- Shares after
- 5,550
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,550
- Exercise price
- $378.08
- Footnotes
- F3
TECH
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +7,400
- Change %
- Price
- $0.000000
- Shares after
- 7,400
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,400
- Exercise price
- $378.08
- Footnotes
- F4
TECH
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 840
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 840
- Exercise price
- Footnotes
- F2, F3
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,984
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,984
- Exercise price
- $401.57
- Footnotes
- F3
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,978
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,978
- Exercise price
- $401.57
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents 2,490 shares of restricted stock for which the risk of forfeiture will lapse as to 830 shares on each of February 1, 2023, February 1, 2024 and February 1, 2025.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Footnote F3
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Footnote F4
Options to purchase 1,850 shares vest on each of 8/15/2023, 8/15/2024, 8/51/2025 and 8/15/2026.
Footnote F5
Options to purchase 995 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 994 shares vest on each of 2/1/2025 and 2/1/2026.